The Daily Galaxy on MSN
Earth has a hidden space barrier… and humans put it there by accident
In a discovery that reads like science fiction, scientists have confirmed that human radio transmissions have formed an ...
Cue the Terminator soundtrack; Foundation's Phantom is itching for deployment.
Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...
A team of AI researchers at Bloomberg have developed PExA, an agentic framework that achieved 70.2% execution accuracy, sharing one of the top positions on the Spider 2.0 (Snow) leaderboard, one of ...
The Pietas program includes classroom work and further research with faculty, engaging in rich intellectual community with your Pietas peers, and developing leadership skills and experience. You will ...
Strong financial position with cash, cash equivalents and short-term investments of $786.5 million as of June 30, 2025 expected to fund projected operations and key clinical milestones through at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback